SEVIKAR

This brand name is authorized in Australia, Austria, Finland, France, Germany, Ireland, Italy, Netherlands, Romania, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug SEVIKAR contains a combination of these active pharmaceutical ingredients (APIs):

1	Olmesartan medoxomil UNII 6M97XTV3HD - OLMESARTAN MEDOXOMIL
	Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations.
	Read more about Olmesartan medoxomil
2	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SEVIKAR Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DB02	Olmesartan medoxomil and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5292M, 5293N, 5294P
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	04712677, 04712683, 04712714, 04712720, 05515826, 06115365, 06115371, 06115388, 07117722, 07117739, 07117745, 07117774, 07117780, 07117797, 07117828, 07117834, 07117840, 07515664, 07517166, 07517284, 07770238, 07770273, 07770304, 07773171, 07773188, 08871243, 09338930, 09340217, 10005984, 10005990, 11322959, 12670131, 13907581, 16200505, 17184837, 17185305, 17185311, 17584703, 17584726, 17584732, 17584749, 17584755, 17584761, 17620592
ES	Centro de información online de medicamentos de la AEMPS	038983161, 038983247, 70069, 70072, 70079
FI	Lääkealan turvallisuus- ja kehittämiskeskus	169484, 169495, 169506, 169517, 169528, 169539
FR	Base de données publique des médicaments	64127633, 64954736, 67023718
GB	Medicines & Healthcare Products Regulatory Agency	157727, 157730, 157733, 374209
IT	Agenzia del Farmaco	038983021, 038983161, 038983247
NL	Z-Index G-Standaard, PRK	88005, 88013, 88021
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68064001, W68064002, W68064003, W68064004, W68064005, W68064006, W68064007, W68064008, W68064009, W68064010, W68064011, W68065001, W68065002, W68065003, W68065004, W68065005, W68065006, W68065007, W68065008, W68065009, W68065010, W68065011, W68066001, W68066002, W68066003, W68066004, W68066005, W68066006, W68066007, W68066008, W68066009, W68066010, W68066011
TN	Direction de la Pharmacie et du Médicament	12803051, 12803052, 12803053
TR	İlaç ve Tıbbi Cihaz Kurumu	8699228090096, 8699228090102, 8699228090119